Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 515

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 515
---
 implemented and enhanced controls, provided we are able to obtain sufficient capital resources to cover
the cost of our remediation plan, are
operating effectively. A failure to implement and maintain effective internal control over financial reporting could result
in errors in our financial statements that could result in a restatement of our financial statements and could cause us to fail to meet
our reporting obligations, any of which could diminish investor confidence in us and cause a decline in the price of our common stock.

Our
independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control over
financial reporting until after we are no longer an “emerging growth company,” as defined in the JOBS Act. At such time,
our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level
at which our internal control over financial reporting is documented, designed, or operating.

Changes
in Internal Control over Financial Reporting

There
have been a number of changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f)
of the Exchange Act) during the most recent fiscal year that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting. These changes include the implementation of enterprise resource planning accounting systems,
and increased accounting and financial reporting consulting resources.

Item
9B. Other Information

During
the fiscal quarter ended December 31, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act)
adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy
the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”.

Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not
applicable.

71

PART
III

Item
10. Directors, Executive Officers and Corporate Governance

Executive
Officers and Directors

The
following table sets forth certain information concerning our executive officers and directors as of March 28, 2025:

    Name
     
    Age
     
    Position
  
    David
    Tapolczay
     
    65
     
    Chief
    Executive Officer and Director
  
    James
    Bligh
     
    37